1. Bruhn H,
Frahm J,
Gyngell ML,
et al.
Noninvasivedifferentiationoftumorswithuse of localized H-1 MR spectroscopy in vivo: initialexperience in patientswithcerebraltumors.
Radiology 1989;172:541–548.
2. Kvistad KA,
Bakken IJ,
Gribbestad IS,
Ehrnholm B,
Lundgren S,
FjosneHE,Haraldseth O.
Characterization of neoplasticand normal humanbreasttissueswith in vivo (1)H MR spectroscopy.
J MagnResonImaging.
1999Aug;10(2):159-64.
3. Sardanelli F,
Fausto A,
DiLeo G,
et al.
Invivo proton MR spectroscopyofthebreastusingthe total cholinepeak integral as a marker ofmalignancy.
AJR Am J Roentgenol 2009;192:1608–1617.
4.TozakiM,SakamotoM,OyamaY,etal.Monitoringofearlyresponsetoneoadjuvantchemotherapy inbreastcancerwith1HMRspectroscopycomparisontosequential2[18F]fluorodeoxyglucosepositronemissiontomography.
J MagnResonImaging 2008;28:420–427.
5.
Baek HM,
Chen JH,
Nie K,
et al.
Predictingpathologicresponsetoneoadjuvantchemotherapy in breastcancerbyusingMRimagingandquantitative 1H MR Spectroscopy.
Radiology 2009;251:653–662.
6 .Bolan PJ,
Meisamy S,
Baker EH,
et al.
Invivoquantificationofcholinecompounds in thebreastwith 1H MR spectroscopy.
MagnResonMed 2003;50:1134–1143.
7 .Stanwell P,
Gluch L,
Clark D,
et al.
Specificity of cholinemetabolitesfor in vivodiagnosis of breast cancer using 1H MRS at 1.5T.EurRadiol 2005;15:1037–1043.
8) D'Orsi CJ,
Bassett LW,
Berg WA,
et al: Breast Imaging Reporting and Data System: ACR BI-RADS-Mammography (ed 4),
Reston,
VA,
American College of Radiology,
2003.
9.Roebuck JR,
Cecil KM,
Schnall MD,
et al.
Humanbreastlesions: characterizationwith proton MRspectroscopy.
Radiology 1998;209:269–75.
10.KatzBrullR,LavinPT,LenkinskiRE.Clinicalutilityofprotonmagneticresonancespectroscopyincharacterizingbreastlesions.
J NatlCancerInst2002;94(16):1197–203.
11.
Kvistad KA,
Bakken IJ,
Gribbestad IS,
et al.
Characterizationofneoplasticand normal humanbreasttissueswith in vivo (1)H MR spectroscopy.
J MagnResonImaging 1999;10(2):159–64.
12.CecilKM,SchnallMD,SiegelmanES,etal.Theevaluationofhumanbreastlesionswithmagneticresonanceimagingandprotonmagneticresonancespectroscopy.BreastCancerResTreat2001;68(1):45–54.
13.
Yeung DK,
Cheung HS,
Tse GM.
Human breastlesions:characterizationwithcontrast-enhancedin vivo proton MR spectroscopy—initialresults.Radiology 2001;220:40–6.
14.
Jagannathan NR,
Kumar M,
Seenu V,
et al.
Evaluationof total cholinefrom in-vivovolumelocalizedproton MR spectroscopyanditsresponsetoneoadjuvantchemotherapy in locallyadvancedbreastcancer.
Br J Cancer 2001;84(8):1016–22.
15.Tse GM,
Cheung HS,
Pang LM,
et al.
Characterizationof lesions of thebreastwith proton MR spectroscopy:comparison of carcinomas,
benignlesions,
andphyllodestumors.
AJR Am J Roentgenol2003;181(5):1267–72.
16.Huang W,
Fisher PR,
Dulaimy K,
et al.
Detectionofbreastmalignancy: diagnostic MR protocolforimprovedspecificity.
Radiology 2004;232(2):585–91.
17.
Bartella L,
Morris EA,
Dershaw DD,
et al.
Proton MRspectroscopywithcholinepeak as malignancymarkerimprovespositivepredictivevalueforbreastcancerdiagnosis: preliminarystudy.
Radiology2006;239(3):686–92.
18.
Bartella L,
Thakur SB,
Morris EA,
et al.
Enhancingnonmasslesions in thebreast: evaluationwithproton(1H) MR spectroscopy.
Radiology 2007;245(1):80–7.
19.
Basara I,
Orguc S,
Coskun T.
Singlevoxel in vivoprotonmagneticresonancespectroscopyofbreastlesions: experience in 77 cases.
DiagnIntervRadiol 2013;19(3):221–6.